1. AMRIN Study Group, 2005. Antimicrobial Resistance, Antibiotic Usage and Infection Control, A Self-Assessment Program For Indonesian Hospitals, Directorate of General Medical Care, Ministry of Health, Republic of Indonesia.
2. Arce JM, Selva M, Perpinan H, Gubernado M, Armero CC, Quilez AL, Gonzales F&Vanaclocha H, 2011. Antimicrobial Resistance According to Age, Gender, Culture Site and Patient Location in more than 100.000 Escherichia coli. Antimicrobagent chemother; vol. 53: pp. 1222-1228
3. Barbosa C, Trebosc V, Kemmer C, Rosenstiel P, Beardmore R, Schulenburg H & Jansen G,2017. Alternative Evolutionary Paths to Bacterial Antibiotic Resistance Cause Distinct Collateral Effects.MolBiolEvol, vol. 34, no. 9, pp. 2229-2244.
4. Bruinsma N, Stobberingh E&P. de Smet, 2003. Antibiotics used and the prevalens of antibiotics resistance in bacteria from healthy volunteers in Dutch community. Infection; no. 1: pp. 9-14.
5. Brunton LL, Chabner BA& Knolimam BC,2011. Goodman and Gilman's The Pharmacological Basis of Therapeutics: Chemotherapy of Microbial Diseases, 12th edn. McGraw-Hi11; chapter 7.